Alexion Pharmaceuticals, Inc.
(NASDAQ : ALXN)

( )
ALXN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.26%203.421.3%$752.26m
GILDGilead Sciences, Inc.
0.14%64.220.9%$374.75m
CELGCelgene Corporation
0.03%95.711.3%$325.97m
ALXNAlexion Pharmaceuticals, Inc.
7.53%123.492.0%$306.94m
ILMNIllumina, Inc.
-0.66%288.583.5%$277.12m
BIIBBiogen Inc.
-0.48%232.061.3%$268.05m
VRTXVertex Pharmaceuticals Incorporated
-1.16%184.241.9%$256.63m
EXASExact Sciences Corporation
-1.14%117.8724.1%$239.89m
REGNRegeneron Pharmaceuticals, Inc.
-0.93%295.022.6%$203.40m
AAgilent Technologies, Inc.
-0.69%71.701.6%$193.78m
SRPTSarepta Therapeutics, Inc.
-6.34%95.0714.7%$184.59m
BMRNBioMarin Pharmaceutical Inc.
-1.05%77.404.3%$97.47m
INCYIncyte Corporation
-0.59%85.562.5%$96.06m
GHDXGenomic Health, Inc.
-1.12%73.521.8%$85.99m
SGENSeattle Genetics, Inc.
-2.01%78.366.5%$79.57m

Company Profile

Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products. Its products include ultomiris, soliris, strensiq and kanuma. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto and Leonard Bell in January 1992 and is headquartered in Boston, MA.